CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$206.31
-0.27 (-0.13%)
▼
5d:
-0.04%
30d:
-10.0%
90d:
-0.95%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 30, 2026
30d
Smart Money Accumulation
CAH is down 4.4% this week, but smart money is accumulating calls. Top strike: $220 2026-06-18 with 947 OI. Call ratio: 63% View Scanner →
Strength: 3.5/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CAH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CAH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$337.61
Based on 8.2% avg growth
INTRINSIC VALUE TODAY
$209.63
1.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $206.31, which is considered oversold relative to its 30-day fair value range of $211.96 to $226.07. The stock's valuation (Forward PE: 17.8) is in line with its historical norms (19.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.3% over the next few years. This pessimistic expectation contrasts with the company's recent 19.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CAH is in a uptrend. The price is currently testing key support at $203.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CAH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $249.60 (+20.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CAH is in a uptrend. The price is currently testing key support at $203.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CAH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $249.60 (+20.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$211.96 -
$226.07
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding CAH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.8% below Wall St target ($249.60)
Fair Price Analysis
30-Day Fair Range
$211.96 -
$226.07
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$203.86
Resistance Level
$218.87
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.84
Wall Street Target
$249.60
(+20.8%)
Revenue Growth (YoY)
18.8%
Earnings Growth (YoY)
19.4%
Profit Margin
0.7%
Valuation Discount vs History
-3.3% cheaper
PE vs Historical
17.8 vs 19.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.3%
(market-implied from PE analysis)
1-Year Target
$199.76
(-3%)
2-Year Target
$193.17
(-7%)
3-Year Target
$186.80
(-10%)
3-Yr Target (if PE normalizes)
(PE: 18→20)
$206.24
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 12.4%)
$367.81
(+78%)
Base:
(SPY PE: 17.8, Growth: 12.4%)
$292.98
(+42%)
Bear:
(PE: 15.2, Growth: 12.4%)
$249.03
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 29.95 | Current EPS (TTM): $6.94
Bull Case
$381.40
(+85%)
Analyst growth 66.8%, PE expands to 32.9
Base Case
$346.73
(+68%)
Market implied 66.8%, PE stable at 30.0
Bear Case
$141.32
(-32%)
Severe decline -20.0%, PE contracts to 25.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.8 to 19.7
Stabilization Target:
$228.09
(+10.4%)
PE Expansion Potential:
+10.4%
Share & Embed Analysis
Last updated: March 30, 2026 4:24 PM ET
Data refreshes hourly during market hours. Next update: 5:24 PM
Data refreshes hourly during market hours. Next update: 5:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-05
Ro Khanna
SELL
2026-01-23
Marjorie Taylor Greene
BUY
2025-10-24
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$998 | 61 BUY |
|
COR
Cencora Inc. |
BUY
17 analysts |
$410 | 59 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$90 | 60 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
